In Vitro |
Anticancer agent 55 (compound 3h) (0-100 µM; 48 h) inhibits cell viability with IC50s of 1.18 µM and 1.95 µM for PC-3, MCF-7 cells, respectively[1]. Anticancer agent 55 (0, 1, 3, 10 µM; 24 h) inhibits cell migration of PC-3 cells and MCF-7 cells in a dose-dependent manner[1]. Anticancer agent 55 (0, 1, 3, 10 µM; 12, 24 h) induces apoptosis by increases the caspase-3 activity and cleaved PARP levels[1]. Cell Viability Assay[1] Cell Line: PC-3, MCF-7 cells Concentration: 0-100 µM Incubation Time: 48 h Result: Significantly inhibited cell viability of PC-3, MCF-7 cells with IC50s of 1.18 µM and 1.95 µM, respectively. Apoptosis Analysis[1] Cell Line: PC-3, MCF-7 cells Concentration: 0, 1, 3, 10 µM Incubation Time: PC-3 for 12 h; MCF-7 for 24 h Result: Induced apoptosis by increased the caspase-3 activity in a concentration-dependent manner. Western Blot Analysis[1] Cell Line: PC-3, MCF-7 cells Concentration: 0, 1, 3, 10 µM Incubation Time: PC-3 for 12 h; MCF-7 for 24 h Result: Increased cleaved PARP levels in a dose-dependent manner in PC-3 and MCF-7 cells.
|